|
|
|
|
| LEADER |
00852nam a22002891a 4500 |
| 003 |
AR-BaBNM |
| 005 |
20251014100514.0 |
| 007 |
ta |
| 007 |
cr ||||||||||| |
| 008 |
130830s2002 sz 000 0 |||||||||spa d |
| 020 |
|
|
|a 92-4-156206-4
|
| 035 |
|
|
|a 000163115
|
| 040 |
|
|
|a AR-BaBNM
|b spa
|e aacr
|
| 080 |
|
|
|a 615.012
|
| 100 |
1 |
|
|a Ratanawijitrasin, Sauwakon
|
| 245 |
1 |
0 |
|a Effective drug regulation :
|b a multicountry study /
|c Sauwakon Ratanawijitrasin, Eshetu Wondemagegnehu.
|
| 260 |
|
|
|a Geneva :
|b WHO,
|c 2002.
|
| 300 |
|
|
|a 142, 47 p.
|
| 610 |
2 |
4 |
|a OMS
|
| 650 |
|
4 |
|a Farmacia
|9 10758
|
| 650 |
|
4 |
|a Medicamentos
|9 8976
|
| 650 |
|
4 |
|a Industria farmacéutica
|9 10913
|
| 650 |
|
4 |
|a Control de calidad
|9 7159
|
| 700 |
1 |
|
|a Wondemagegnehu, Eshetu
|
| 856 |
4 |
|
|u http://whqlibdoc.who.int/hq/2002/9241562064.pdf
|
| 942 |
|
|
|2 udc
|c DIGI
|n 1
|
| 999 |
|
|
|c 155880
|d 155880
|